1. Home
  2. ORIC vs PDLB Comparison

ORIC vs PDLB Comparison

Compare ORIC & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • PDLB
  • Stock Information
  • Founded
  • ORIC 2014
  • PDLB 1960
  • Country
  • ORIC United States
  • PDLB United States
  • Employees
  • ORIC N/A
  • PDLB N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • PDLB
  • Sector
  • ORIC Health Care
  • PDLB
  • Exchange
  • ORIC Nasdaq
  • PDLB Nasdaq
  • Market Cap
  • ORIC 362.9M
  • PDLB 316.6M
  • IPO Year
  • ORIC 2020
  • PDLB 2017
  • Fundamental
  • Price
  • ORIC $10.05
  • PDLB $14.29
  • Analyst Decision
  • ORIC Strong Buy
  • PDLB
  • Analyst Count
  • ORIC 8
  • PDLB 0
  • Target Price
  • ORIC $18.83
  • PDLB N/A
  • AVG Volume (30 Days)
  • ORIC 1.3M
  • PDLB 39.1K
  • Earning Date
  • ORIC 08-11-2025
  • PDLB 07-29-2025
  • Dividend Yield
  • ORIC N/A
  • PDLB N/A
  • EPS Growth
  • ORIC N/A
  • PDLB 148.96
  • EPS
  • ORIC N/A
  • PDLB 0.60
  • Revenue
  • ORIC N/A
  • PDLB $86,682,000.00
  • Revenue This Year
  • ORIC N/A
  • PDLB $10.97
  • Revenue Next Year
  • ORIC N/A
  • PDLB $8.59
  • P/E Ratio
  • ORIC N/A
  • PDLB $23.17
  • Revenue Growth
  • ORIC N/A
  • PDLB 18.40
  • 52 Week Low
  • ORIC $3.90
  • PDLB $9.01
  • 52 Week High
  • ORIC $14.67
  • PDLB $14.06
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 63.99
  • PDLB 61.61
  • Support Level
  • ORIC $10.05
  • PDLB $12.81
  • Resistance Level
  • ORIC $10.99
  • PDLB $14.06
  • Average True Range (ATR)
  • ORIC 0.60
  • PDLB 0.27
  • MACD
  • ORIC -0.07
  • PDLB 0.07
  • Stochastic Oscillator
  • ORIC 54.67
  • PDLB 86.80

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

Share on Social Networks: